United States · Series A startup

Who invested in Tome Biosciences

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$213Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $213MDec 2023
Investors
5
See who backed them

The rounds

  1. Dec 2023

Everyone who backed them

Andreessen HorowitzVC firm1round
Google VenturesCorporate VC1round
Polaris PartnersVC firm1round
Longwood FundVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tome Biosciences

Who invested in Tome Biosciences?

Tome Biosciences's investors include Andreessen Horowitz, Google Ventures, Polaris Partners, ARCH Venture Partners and Longwood Fund.

How much has Tome Biosciences raised?

Tome Biosciences has raised $213M across 1 round since 2023.

When did Tome Biosciences last raise?

Tome Biosciences's most recent round was a Series A of $213M in Dec 2023.

What was Tome Biosciences's biggest round?

Its most recent round, $213M in Dec 2023, is also its largest on record.

Who backed Tome Biosciences first?

Tome Biosciences's first round on record, in Dec 2023, was backed by Andreessen Horowitz, Google Ventures and Polaris Partners and 2 others.

What stage is Tome Biosciences at?

Tome Biosciences's latest named round is a Series A, in Dec 2023.

Where is Tome Biosciences based?

Tome Biosciences is based in the United States.

Companies like Tome Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.